Results 71 to 80 of about 2,458,624 (375)

Development of Carbon‐11 Labeled Pyrimidine Derivatives as Novel Positron Emission Tomography (PET) Agents Enabling Brain Sigma‐1 Receptor Imaging

open access: yesAdvanced Science, EarlyView.
Novel carbon‐11 labeled pyrimidine derivatives are developed as PET imaging probes for visualizing sigma‐1 receptors in the brain. [11C]CNY‐01 demonstrates superior brain uptake and binding specificity in both rodents and non‐human primates. The study reveals decreased sigma‐1 receptor expression in Alzheimer's disease, offering a promising tool for ...
Ping Bai   +12 more
wiley   +1 more source

Opioid use Disorder for Prescription Opioid Medications

open access: yesGlobal Journal of Addiction & Rehabilitation Medicine, 2017
Why are opioid medications prescribed in large quantities and high frequency when there is little or no proven efficacy for their therapeutic value? Why are opioids the most commonly prescribed medication in the United States for the past decades when the adverse consequences continue to grow and mount?
openaire   +2 more sources

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018

open access: yesAddiction Science & Clinical Practice, 2022
Background Medications to treat opioid use disorder (OUD) including buprenorphine products are evidence-based and cost-effective tools for combating the opioid crisis.
Kevin P. Conway   +5 more
doaj   +1 more source

Intraoperative Dexmedetomidine Administration Effects on Postoperative Pain Scores and Opioid Medication Requirements: Pain Management Expectations Among CRNAs [PDF]

open access: yes, 2022
Opioid pain medications are currently viewed as a standard part of pain control in the vast majority of surgical procedures. However, opioid pain medications can have harmful effects on patients leading to increased length of hospital stay, unplanned ...
Bodine, Matthew   +2 more
core   +1 more source

"Can We Detect Substance Use Disorder?": Knowledge and Time Aware Classification on Social Media from Darkweb [PDF]

open access: yesarXiv, 2023
Opioid and substance misuse is rampant in the United States today, with the phenomenon known as the "opioid crisis". The relationship between substance use and mental health has been extensively studied, with one possible relationship being: substance misuse causes poor mental health.
arxiv  

The Lung Microbiome Modulates Pain‐Like Behavior Via the Lung–Brain Axis in a Nitroglycerin‐Induced Chronic Migraine Mouse Model

open access: yesAdvanced Science, EarlyView.
Intratracheal neomycin alters pulmonary microbiota, activating the vagus nerve via lung brain‐derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB) pathway, further projecting to nucleus of solitary tract (NTS), then dorsal raphe nucleus (DRN), where activated serotoninergic neurons increase brain serotonin, alleviating migraine.
Biying Liu   +7 more
wiley   +1 more source

Rapid Access to Medications for Opioid Use Disorder [PDF]

open access: yesJournal of General Internal Medicine, 2021
Robert A. Kleinman, Nathaniel P. Morris
openaire   +3 more sources

Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review [PDF]

open access: yesJournal of General Internal Medicine, 2020
Despite evidence that medications to treat opioid use disorder (OUD) are effective, most people who could benefit from this treatment do not receive it. This rapid review synthesizes evidence on current barriers and facilitators to buprenorphine/naloxone and naltrexone at the patient, provider, and system levels to inform future interventions aimed at ...
Johanna Anderson   +4 more
openaire   +3 more sources

Impact of recent methamphetamine use on treatment outcomes among individuals initiating medications for opioid use disorders in rural treatment settings: a 1-year retrospective cohort study

open access: yesRural and Remote Health
Introduction: Rates of N-methylamphetamine (methamphetamine) use in rural areas of the US have been steadily increasing, particularly among individuals who are already struggling with opioid use disorder.
Leslie Kenefick   +9 more
doaj   +1 more source

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

open access: yesHarm Reduction Journal, 2021
Background For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine ...
Heather Palis   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy